These findings suggest that the level of Chk1 expression or activation status of enzymes regulating the M-phase entry, such as cdc25 and cdc2-cyclin B complex, may play an important role in determining sensitivity or resistance of tumor cells to HDACis. Here, CHEK1 is linked to neoplasm.